Every SEC Form 3/4/5 on record for this filer (CIK 1340823) — 7 issuers, 99 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | Director | 2021-05-27 → 2026-06-24 | 6 | — |
| VEEV | VEEVA SYSTEMS INC | Director | 2019-08-19 → 2026-06-22 | 43 | −$146,380 |
| LLY | ELI LILLY & Co | Director | 2022-05-16 → 2025-12-16 | 46 | — |
| MLND | Millendo Therapeutics, Inc. | Director · lapsed | 2018-12-11 → 2020-06-23 | 5 | — |
| TSRO | TESARO, Inc. | President & COO · Director · lapsed | 2016-03-03 → 2019-01-22 | 5 | −$908,960 |
| BLUE | bluebird bio, Inc. | Director · lapsed | 2017-09-20 → 2018-06-22 | 3 | — |
| RCPT | Receptos, Inc. | Director · lapsed | 2015-08-27 → 2015-08-27 | 1 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
2 of 7 issuers are covered and open a security page; the rest are on file here only.
